EUROQOL | News
First EuroQol approved sign language version of the EQ-5D-5L is now available
EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and…
Chinese version of the EQ-5D-5L User Guide now available for download
The EuroQol Office is pleased to announce that the EQ-5D-5L User Guide is now available in Chinese (Mandarin). The User Guide provides readers with basic information on how to use the EQ-5D-5L questionnaire. Topics include…
International valuation protocol for the EQ-5D-Y published
EuroQol is pleased to announce that, following an extensive programme of methodological research, an international evidence-based valuation protocol has been developed for the EQ-5D-Y instrument. Published in PharmacoEconomics, the new valuation protocol will enable the…
EQ-5D licenses for COVID-19 related research
EuroQol is committed to improve decisions about health and health care throughout the world by making available EQ-5D for research on the impact of COVID-19. The EQ Office Team is handling all requests for using…
Notice to website visitors and customers
As a result of the Covid-19 crisis the EuroQol Office team is working from home. We are doing our best to guarantee the level of service that you have become accustomed to. However, the current…
EuroQol launches a new whiteboard animation, ‘How to obtain EQ-5D’.
EuroQol is pleased to launch a new whiteboard animation, ‘How to obtain EQ-5D’. The animation is intended for anyone interested in using EQ-5D. It describes the process of registering and gaining access to the instrument,…
Explaining the EQ-5D in about two-and-a-half-minutes’ animation now also available in Chinese, Japanese and Spanish
EuroQol is pleased to launch the Chinese (Mandarin), Japanese and Spanish version of the whiteboard animation ‘Explaining the EQ-5D in about two-and-a-half-minutes’. The animation is intended for anyone interested in EQ-5D, one of the most…
New EQ-5D-5L valuation study for England to be undertaken by EuroQol in collaboration with NICE and the Department of Health and Social Care and NHS England
NICE has announced on their website today their decision to support the development of a new EQ-5D-5L valuation study for England. The new study will be funded and managed by the EuroQol Group, with ongoing…
Summary slide kit on EuroQol and EQ-5D now available
EuroQol has developed a summary slide kit providing a summary of the EuroQol Group, the EQ-5D measure, use of EQ-5D, availability of value sets and translations, information on how to obtain EQ-5D for use in…
‘Explaining the EQ-5D in about two-and-a-half-minutes’ – EuroQol launches its first whiteboard animation
EuroQol is pleased to launch a whiteboard animation ‘Explaining the EQ-5D in about two-and-a-half-minutes’. The animation is intended for anyone interested in EQ-5D, one of the most widely used measures of patient reported outcomes. It…